NASDAQ:ALGN - Align Technology Stock Price, Forecast & News

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings data on Wednesday, October, 23rd. The medical equipment provider reported $1.28 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.14 by $0.14. The medical equipment provider had revenue of $607.30 million for the quarter, compared to analysts' expectations of $595.29 million. Align Technology had a return on equity of 28.76% and a net margin of 18.28%. Align Technology's revenue for the quarter was up 20.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.24 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Align Technology.

Align Technology will be holding an earnings conference call on Wednesday, January 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

12 brokers have issued 1-year price targets for Align Technology's stock. Their forecasts range from $200.00 to $360.00. On average, they expect Align Technology's share price to reach $266.45 in the next twelve months. This suggests that the stock has a possible downside of 4.6%. View Analyst Price Targets for Align Technology.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Media headlines about ALGN stock have been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Align Technology earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Align Technology.

Some companies that are related to Align Technology include Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Adobe (ADBE), Micron Technology (MU), Paypal (PYPL), Visa (V), salesforce.com (CRM), Boeing (BA) and Mastercard (MA).

Align Technology's stock is owned by a number of of institutional and retail investors. Top institutional investors include Johanson Financial Advisors Inc. (0.06%), Commerzbank Aktiengesellschaft FI (0.06%), Zurcher Kantonalbank Zurich Cantonalbank (0.06%), Nisa Investment Advisors LLC (0.05%), Gateway Investment Advisers LLC (0.04%) and Scout Investments Inc. (0.04%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Courier Capital LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Janney Montgomery Scott LLC, State of Alaska Department of Revenue, Commerzbank Aktiengesellschaft FI, Gateway Investment Advisers LLC, Brasada Capital Management LP and IFM Investors Pty Ltd. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was bought by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Scout Investments Inc., Zurcher Kantonalbank Zurich Cantonalbank, Nisa Investment Advisors LLC, Alpine Global Management LLC, Steward Partners Investment Advisory LLC, Zeke Capital Advisors LLC and Ballentine Partners LLC. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $279.31.

Align Technology has a market capitalization of $22.01 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]